A recent study reveals that CMA is activated in renal carcinoma cells and can promote the proliferation and invasion of renal carcinoma cells through pyruvate kinase isoform M2 (PKM2) in vitro [62], which plays a crucial role in cancer progression [88]. The gene discussed is PKM; the disease is renal carcinoma.